Interestingly, while exact BRCA1 mutational status could not be determined, we also found that urinary levels of IL-1β were 3 times higher among women with benign ovarian disease and a FH of breast/ovarian cancer compared with women with benign ovarian disease and lacking a FH of breast/ovarian cancer. This evidence concerns the gene IL1B and ovarian carcinoma.